FLORTAUCIPIR F-18 for neurodegenerative diseases

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 23 Aug 2016: Trial started, NCT03143374
  2. 8 May 2017: Trial registered, NCT03143374

The trials

NCT03143374: PET Tau - Neurodegenerative Disease Imaging

State
Under way
Phase
Phase 2 and Phase 3
People
300 planned
Started
23 Aug 2016
Primary completion
Sep 2030
Arms
Positron Emission Tomography (PET/CT) Imaging of Tau Pathology in Neurodegenerative Disease
Results
None posted
  1. 23 Aug 2016: Trial started
  2. 8 May 2017: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Tauvid.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.